Adição na publicação
#15.35
07/13/2021
RPI 2636
Application data
Number
112014010492Type
Filing
Publication
PCT
US2012062999 The application was abandoned: examination was not requested within the 36 months following the 11/01/2012 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 07/13/2021. We update with every new RPI gazette, published weekly.
Applicants
EXELIXIS, INC
US
SANOFI
FR
Inventors
A. D. (pessoa física)
US
J. L. (pessoa física)
US
IPC Classification
Priority claims
US
61/553,990 · 11/01/2011
US
61/568,189 · 12/08/2011
Abstract
N-(3-{[{3-{[2-CLORO-5-(METÃXI)FENIL]AMINO}QUINOXALIN-2- IL)AMINO]SULFONIL}FENIL)-2-METILALANINAMIDA COMO INIBIDOR DE FOSFATIDILINOSITOL 3-CINASE PARA O TRATAMENTO DE MALIGNIDADES LINFOPROLIFERATIVAS .Métodos são fornecidos para tratar urna linfoproliferativa para um paciente em necessidade de tal tratamento, compreendendo administrar ao paciente uma quantidade eficaz do composto A conforme descrito neste documento.
Publications in the Brazilian Industrial Property Gazette (RPI).
#15.35
07/13/2021
RPI 2636
#11.1.1
09/05/2017
RPI 2435
#11.1
05/02/2017
RPI 2417
Vide e-parecer
05/02/2017
RPI 2417
#1.3
04/25/2017
RPI 2416
#1.1
10/21/2014
RPI 2285
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.